Orthopedic Implant Patents: Top Companies & Filing Trends 2026
- Filing has cooled since the 2020 peak. 137 families in 2020 versus 72 in 2017 and a partial 16 in 2026 — the mid-decade surge has not been sustained.
- A61F dominates the classification mix. 2,455 of 2,685 records sit in implants and prostheses, with A61B surgical technique and A61L sterilisation trailing far behind as secondary claim territory.
- Momentum has gone quiet at the top of the ranking. Several long-standing assignees show zero filings in the latest year, while smaller entrants like Canary Medical post outsized percentage swings off a small base.
What the orthopedic implant patent record actually shows
Orthopedic implant patenting covers the mechanical and biological problem of putting a device inside a joint or bone and having it stay there: osseointegration, wear debris control, porous structure design and the practicalities of modularity and revision surgery. The search underlying this page pulls 2,685 published families from 2015 through mid-2026, filtered to records that combine implant or prosthesis claim language with at least one of those functional terms and sit inside the A61F2, A61L27 or A61B17 classification families.
Publication lags filing by roughly 18 months, so the 2026 figure in any trend line understates true filing activity for that year. Read the last one to two years as a floor, not a ceiling.
Filing trend and technology composition
Two views of the same 2,685-family dataset: how filing volume has moved year over year, and which IPC subclasses carry the claim density.
Filing peaked in 2020 and has not recovered
Annual filings rose from 72 in 2017 to a peak of 137 in 2020, held near the midpoint at 108 in 2022, and have declined since — a pattern consistent with a maturing claim space rather than an expanding one.
Implants and prostheses carry the claim weight
A61F accounts for 2,455 of 2,685 records. A61B (surgical technique, 840) and A61L (sterilising and disinfecting, 415) are meaningful secondary layers; powder metallurgy, coatings and digital-data processing subclasses each sit under 60 records, marking them as thin, specialist filing zones rather than core territory.
Shares are the percentage of the 2,685 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Orthopedic Implant Technology with Eureka
This page is one run against one query. Ask Eureka your own question about orthopedic implant technology and every answer comes back with the patent numbers behind it.
Try EurekaThe most-cited records anchoring this field
Orthopedic implant with porous structure having varying coefficient of friction with bone
The implant body carries a porous structure running circumferentially around it, with one zone set to a lower coefficient of friction against bone tissue and a second, offset zone set higher. The differential-friction approach targets controlled seating and fixation behaviour rather than a single uniform bone-contact surface.Filed by BIOMEDTRIX, LLC; published 2024-02-08 as US20240041605A1.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US20020035400A1 | Implantable joint prosthesis | 665 |
| 2 | US6520996B1 | Orthopedic implant | 604 |
| 3 | US4944757A | Modulator knee prosthesis system | 564 |
| 4 | US7025787B2 | Implantable joint prosthesis and associated instrumentation | 514 |
| 5 | US20030135277A1 | Implantable joint prosthesis and associated instrumentation | 487 |
| 6 | US20020128715A1 | Implantable joint prosthesis | 467 |
| 7 | US20050027361A1 | Facet arthroplasty devices and methods | 461 |
| 8 | US5871546A | Femoral component condyle design for knee prosthesis | 439 |
| 9 | US5906644A | Adjustable modular orthopedic implant | 412 |
| 10 | US5194066A | Modular joint prosthesis | 371 |
Citation counts inside a searched corpus skew toward older filings simply because they have had longer to accumulate references — treat this table as a map of foundational art, not of current commercial weight.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →Reading the filing pattern
Three things the trend and classification data support without extrapolating beyond what is in the corpus.
The surge has passed its high point
Annual filings climbed from 72 in 2017 to 137 in 2020, sat at 108 by 2022, and have fallen since. Even allowing for publication lag understating the last year or two, the shape is a decline from a mid-decade peak, not sustained growth.
Claim space is concentrated in the implant body itself
The gap between A61F (2,455) and the next subclass, A61B at 840, shows most inventive effort is still spent on the implant and prosthesis structure rather than on the surrounding surgical technique, sterilisation process or digital tooling.
Filing is US-anchored with a thinner international tail
The United States receives the largest share of filings at 912, with Europe and Australia as secondary offices and WIPO PCT and China filings smaller still. A filing strategy built only around the US receiving office will miss activity that shows up first at EPO.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to orthopedic implant technology, with the prior art for and against each one.
Who is filing, and who has gone quiet
Assignee momentum in the latest year is mixed: some established names show no new filings at all, while a few smaller entrants post large percentage swings off a low base.
Small entrants can post large percentage swings
Canary Medical moved from 1 to 2 filings in the latest year — a 100% increase in percentage terms, but a small absolute change. Read momentum percentages alongside the underlying count, not instead of it.
Established names show no latest-year activity
DePuy Products, Zimmer (US) and DePuy Ireland all show zero filings in the latest year in this dataset, with Zimmer (US) down 100% year over year. That does not mean these organisations have exited the field — it may reflect publication lag or a shift in filing entity — but it is a visible gap worth checking against other sources.
Coating partnerships show up as the strongest co-assignee pair
The strongest co-assignee link in the dataset pairs DePuy International with Ionbond Limited across 6 families, pointing to a surface-coating collaboration pattern layered on top of core implant claims.
| Assignee | Recent year | YoY |
|---|---|---|
| Howmedica Osteonics Corp. | 2 | -75% |
| Canary Medical Inc. | 2 | +100% |
| DePuy Products, Inc. | 0 | — |
| Zimmer, Inc. (US) | 0 | -100% |
| DePuy (Ireland) | 0 | — |
| AstraZeneca UK Limited | 0 | — |
| Waldemar Link GmbH & Co. KG | 0 | -100% |
| Biomet Manufacturing, LLC | 0 | — |
Where to take this analysis
The trend and classification data point to specific next checks rather than a single conclusion.
Confirm the decline is not a lag artefact
Because publication lags filing by around 18 months, the 2025-2026 drop should be re-checked once later data cuts land before concluding the field has genuinely cooled.
Model filing scenarios in EurekaMap the coating and porous-structure niche
B22F, B29C and C23C subclasses each sit under 60 records — small enough to review individually for open claim positions around porous structure and surface treatment.
Explore white space in EurekaTrack assignees with zero recent filings
Several established names show no latest-year activity in this corpus; confirming whether that reflects a real pullback or an entity change affects how competitive the field looks going forward.
Set up assignee alerts in EurekaCommon questions on orthopedic implant patents
The most-cited records in this corpus include US20020035400A1, US6520996B1, US4944757A, US7025787B2 and US20030135277A1, covering implantable joint prosthesis designs and associated instrumentation. High citation counts inside a searched corpus tend to favour older filings, since they have had longer to accumulate references, so treat these as foundational prior art rather than a current market-share signal. For a picture of who is filing now, look at the recent-year momentum data rather than the citation ranking.
Filing rose from 72 families in 2017 to a peak of 137 in 2020, held near 108 by 2022, and has declined since, with only 16 recorded so far in the partial 2026 year. Because publication typically lags actual filing by about 18 months, the most recent one to two years will always look lower than they eventually turn out to be. Even accounting for that lag, the overall shape across the decade is a mid-period peak followed by a slowdown rather than continued growth.
A61F, covering implants and prostheses, accounts for 2,455 of the 2,685 records in this dataset, making it by far the dominant classification. A61B, which covers diagnosis and surgical technique, follows with 840 records, and A61L, sterilising and disinfecting, has 415. Subclasses tied to powder metallurgy, plastics shaping, surface coating and digital data processing each sit under 60 records, marking them as narrow specialist areas rather than core filing territory.
The classification data shows thin filing activity in powder metallurgy (B22F, 57 records), plastics shaping (B29C, 47), surface coating and deposition (C23C, 44), and digital data processing (G06F, 43) relative to the 2,455-record core in A61F. These smaller subclasses point to under-claimed intersections such as coefficient-of-friction gradient coatings, powder-based porous scaffolds, and sensor-integrated implant monitoring. Any of these would need a targeted freedom-to-operate search rather than relying on the aggregate numbers alone.
The United States receiving office leads with 912 filings, followed by Europe (EPO) at 498 and Australia at 266. WIPO PCT filings total 260 and China 180, with Canada at 135. A filing or clearance strategy focused only on the US will miss a substantial share of activity that surfaces first at the EPO or through PCT applications, so multi-jurisdiction searching matters for this field.
Research Orthopedic Implant Technology in depth with Eureka
Go past this page: query the whole orthopedic implant technology corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.